articleThe LancetMar 1, 2005GREEN OA

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial

Centre d'Investigation Clinique - Innovation Technologique · Hammersmith Hospital · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

633
total citations
FWCI
33.12
Percentile
100%
References
30
Citations per year

Authors

7

Topics & keywords

Keywords
  • Rasagiline
  • Entacapone
  • Placebo
  • Levodopa
  • Selegiline
  • Medicine
  • Parkinson's disease
  • Dyskinesia
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding